Canada markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.33000.0000 (0.00%)
At close: 03:14PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.19
52-Week Change 3133.33%
S&P500 52-Week Change 3-6.78%
52 Week High 31.7600
52 Week Low 30.2400
50-Day Moving Average 30.9026
200-Day Moving Average 30.5196

Share Statistics

Avg Vol (3 month) 36.19k
Avg Vol (10 day) 3130
Shares Outstanding 54.09M
Implied Shares Outstanding 6N/A
Float 82.77M
% Held by Insiders 135.16%
% Held by Institutions 14.86%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)-1,589.59%

Management Effectiveness

Return on Assets (ttm)-24.50%
Return on Equity (ttm)-38.02%

Income Statement

Revenue (ttm)567k
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)-97.50%
Gross Profit (ttm)6.07M
Net Income Avi to Common (ttm)-7.25M
Diluted EPS (ttm)-0.2980
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.77M
Total Cash Per Share (mrq)3.86
Total Debt (mrq)966k
Total Debt/Equity (mrq)6.93
Current Ratio (mrq)3.88
Book Value Per Share (mrq)3.41

Cash Flow Statement

Operating Cash Flow (ttm)-8.98M
Levered Free Cash Flow (ttm)-2.44M